1. 149P Revamping the ovarian tumour microenvironment with an oncolytic adenovirus yields enhanced tumour-infiltrating lymphocyte anti-tumour activity. (15th December 2019) Authors: Santos, J M; Heiniö, C; Cervera-Carrascon, V; Siurala, M; Quixabeira, D C A; de Gruijl, T; Lassus, H; Kanerva, A; Hemminki, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P03.31 Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. (1st October 2020) Authors: Prokopi, N; Tripp, CH; Tummers, B; Crawford, JC; Efremova, M; Hutter, K; Bellmann, L; Cappellano, G; Boon, L; Ortner, D; Trajanoski, Z; Chen, S; de Gruijl, T; Green, DR; Stoitzner, P Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P09.02 Mapping and tackling tumor and chemotherapy-induced immune suppression in breast cancer sentinel lymph nodes. (1st October 2020) Authors: Prokopi, N; Heeren, M; Milenova, I; van Pul, K; Muijlwijk, T; Arends, M; van der Velde, S; Vrijland, K; van Weverwijk, A; de Visser, K; van de Ven, R; de Gruijl, T Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗